Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 26, 2024 2024-03-13 18:00
Sanyou Biopharmaceuticals Launches Advanced Intelligent R&D Service Platform 2024-03-13 09:00
AITRICS to Participate in HIMSS USA 2024 2024-03-12 22:50
Datasea to Drive Growth in its Acoustic Business via Product Upgrades and U.S. Market Entry 2024-03-12 22:40
Mabwell to Present Pre-clinical Results at the 2024 American Association for Cancer Research (AACR) Annual Meeting 2024-03-12 22:00
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications 2024-03-12 20:30
GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30% 2024-03-12 20:15
Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD 2024-03-12 20:00
Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders 2024-03-12 19:00
Everest Medicines' Partner Calliditas Therapeutics Announces U.S. FDA Grants an Additional Seven-Year Orphan Drug Exclusivity Period for Nefecon® 2024-03-12 09:28
Casio to Release Uterocervical Observation Camera in the United States, Australia and New Zealand 2024-03-12 09:00
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination 2024-03-12 04:30
Mabwell to Present ADC Platform IDDC™ and the Latest Study Results of Multiple Novel ADCs at the 14th World ADC London 2024-03-11 22:00
Medicilon has appointed Dr. Qingcong Lin as President of Medicilon USA Corp., further deepening the global strategic layout 2024-03-11 20:30
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University 2024-03-11 20:00
TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer 2024-03-11 20:00
AirNet Announces Changes in the Board of Directors 2024-03-11 16:00
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting 2024-03-11 08:10
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity 2024-03-08 23:24
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range 2024-03-08 22:02
1 7 8 9 10 11 762